Spok (NASDAQ:SPOK) Upgraded to “Hold” at B. Riley

B. Riley upgraded shares of Spok (NASDAQ:SPOK) to a hold rating in a report released on Wednesday, Zacks.com reports.

Separately, StockNews.com downgraded shares of Spok from a buy rating to a hold rating in a report on Thursday.

Spok Stock Up 0.1 %

NASDAQ:SPOK opened at $14.99 on Wednesday. Spok has a 52 week low of $13.24 and a 52 week high of $18.14. The stock’s fifty day moving average is $15.11 and its two-hundred day moving average is $15.29. The company has a market capitalization of $303.49 million, a P/E ratio of 18.06 and a beta of 0.33.

Spok (NASDAQ:SPOK) last issued its quarterly earnings data on Wednesday, July 24th. The Wireless communications provider reported $0.17 earnings per share (EPS) for the quarter. The firm had revenue of $33.98 million during the quarter. Spok had a return on equity of 9.56% and a net margin of 11.19%.

Spok Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, September 9th. Stockholders of record on Monday, August 19th were given a dividend of $0.313 per share. The ex-dividend date was Monday, August 19th. This represents a $1.25 annualized dividend and a dividend yield of 8.35%. Spok’s dividend payout ratio is presently 150.60%.

Insider Activity at Spok

In related news, CEO Vincent D. Kelly sold 45,000 shares of Spok stock in a transaction on Monday, August 19th. The stock was sold at an average price of $14.83, for a total value of $667,350.00. Following the completion of the transaction, the chief executive officer now directly owns 201,645 shares in the company, valued at $2,990,395.35. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other Spok news, COO Michael W. Wallace sold 25,000 shares of the stock in a transaction that occurred on Tuesday, August 20th. The shares were sold at an average price of $14.80, for a total value of $370,000.00. Following the sale, the chief operating officer now directly owns 49,465 shares of the company’s stock, valued at approximately $732,082. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Vincent D. Kelly sold 45,000 shares of Spok stock in a transaction on Monday, August 19th. The stock was sold at an average price of $14.83, for a total transaction of $667,350.00. Following the sale, the chief executive officer now directly owns 201,645 shares of the company’s stock, valued at $2,990,395.35. The disclosure for this sale can be found here. Company insiders own 11.88% of the company’s stock.

Institutional Trading of Spok

A number of institutional investors have recently bought and sold shares of the business. Janney Montgomery Scott LLC acquired a new stake in shares of Spok during the 4th quarter worth about $681,000. Campbell & CO Investment Adviser LLC raised its holdings in Spok by 12.9% during the fourth quarter. Campbell & CO Investment Adviser LLC now owns 55,951 shares of the Wireless communications provider’s stock worth $866,000 after purchasing an additional 6,392 shares in the last quarter. Tucker Asset Management LLC acquired a new stake in Spok during the 4th quarter worth $126,000. Hennion & Walsh Asset Management Inc. lifted its position in Spok by 61.6% in the first quarter. Hennion & Walsh Asset Management Inc. now owns 34,738 shares of the Wireless communications provider’s stock valued at $554,000 after acquiring an additional 13,245 shares during the last quarter. Finally, Principal Financial Group Inc. purchased a new position in shares of Spok during the first quarter worth about $170,000. 50.81% of the stock is owned by hedge funds and other institutional investors.

Spok Company Profile

Spok Holdings, Inc, through its subsidiary, Spok, Inc, provides healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. The company's products and services enhance workflows for clinicians and support administrative compliance. It delivers clinical information to care teams when and where it matters to enhance patient outcomes; and provides GenA Pager, a one-way alphanumeric pager.